Skip to main content
. 2020 Jun 18;2020:8839506. doi: 10.1155/2020/8839506

Table 1.

Characteristics of the subjects.

All Survivor Nonsurvivor p
n Results n Results n Results
Age (years) 447 68 (56–79) 361 66 (56–78) 86 75 (61–82) 0.003
Gender (M/F) 447 213/234 361 172/189 86 41/45 1.000
Ethnicity (white/others) 447 320/127 361 246/115 86 74/12 0.001
Hematology
 WBC (109/L) 447 8.7 (6.4–12.9) 361 8.5 (6.4–12.0) 86 10.6 (6.3–15.9) 0.034
 Neutrophil (%) 184 84 (74–90) 143 84 (74–90) 41 85 (76–91) 0.398
 Lymphocyte (%) 183 9 (5–16) 142 10 (6–16) 41 6 (4–10) 0.008
 NLR 183 9.1 (4.7–17.2) 142 8.3 (4.5–15.1) 86 11.4 (7.9–25.2) 0.024
 Hemoglobin (g/L) 447 105 (92–120) 361 106 (92–120) 86 101 (89–118) 0.362
 RDW (%) 447 15.5 (14.2–17.2) 361 15.4 (14.2–17.2) 86 15.7 (14.2–17.2) 0.690
 MCV (fl) 447 90 (86–94) 361 90 (86–95) 86 90 (85–94) 0.358
 MCH (pg) 447 29.6 (27.9–31.4) 361 29.6 (28.0–31.5) 86 29.6 (27.8–30.8) 0.230
 MCHC (g/L) 447 327 (317–338) 361 328 (318–339) 86 325 (317–336) 0.336
Comorbidity
 CHF (Y/N) 447 230/217 361 199/162 86 31/55 0.002
 Liver disease (Y/N) 447 45/402 361 32/329 86 13/73 0.125
 Renal failure (Y/N) 447 117/330 361 99/262 86 18/68 0.218
 Hypertension (Y/N) 447 247/200 361 209/152 86 38/48 0.029
 Cardiac arrhythmias (Y/N) 447 174/273 361 138/223 86 36/50 0.619
 Valvular disease (Y/N) 447 74/373 361 62/299 86 12/74 0.575
 CPD (Y/N) 447 193/254 361 158/203 86 35/51 0.693
 Hypothyroidism (Y/N) 447 63/384 361 55/306 86 8/78 0.212
Final diagnosis
 Heart failure 447 65 361 56 86 9 0.233
 Pneumonia 447 35 361 28 86 7 0.905

WBC: white blood cell; NLR: neutrophil-to-lymphocyte ratio; RDW: red blood cell distribution width; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; CHF: congestive heart failure; CPD: chronic pulmonary disease.